SCHEMBL4227286

SCHEMBL4227286

O=c1c2sccc2nc(CCCNc2ncnc3c2ncn3C2CCCCO2)n1-c1cc(F)cc(F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ CYP1A2 P05177 2/20 0.43
▸ HPGD P15428 1/20 0.43
▸ CYP2C19 P33261 1/20 0.37
▸ TSHR P16473 1/20 0.35
▸ YTHDC1 Q96MU7 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ APEX1 P27695 1/20 0.35
▸ PI4KA P42356 1/20 0.35
▸ BLM P54132 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ ADCY1 Q08828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4228491 0.91 NPC1 (0.53) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL4227217 0.90 SMN1; SMN2 (0.46) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL4237005 0.89 NPC1 (0.46) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL4233647 0.88 NPC1 (0.45) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL4237270 0.86 PIK3CD (0.49) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL4229018 0.85 SMN1; SMN2 (0.42) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL1704013 0.82 NPC1 (0.42) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL12471910 0.78 NPC1 (0.55) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL4232120 0.77 PIK3CD (0.38) RAB9ASMN1; SMN2MEN1ALDH1A1KMT2A
SCHEMBL16670935 0.74 NPC1 (0.53) NPC1RAB9ASMN1; SMN2CYP1A2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097422-A1 THIENOPYRIMIDINONES FOR TREATMENT OF INFLAMMATORY DISORDERS AND CANCERS Eli Lilly & Co. (US) 2009-09-09 — — EP disclosed
WO-2008064018-A1 THIENOPYRIMIDINONES FOR TREATMENT OF INFLAMMATORY DISORDERS AND CANCERS ELI LILLY & CO. (US) 2008-05-29 — — WO disclosed
Send feedback